Perk Labs Inc.
PERK
CNSX
| 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | 08/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 46.80K | 43.50K | 19.20K | 24.30K | 20.80K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 46.80K | 43.50K | 19.20K | 24.30K | 20.80K |
| Cost of Revenue | 43.40K | 39.90K | 15.80K | 17.10K | 13.00K |
| Gross Profit | 3.30K | 3.60K | 3.40K | 7.20K | 7.80K |
| SG&A Expenses | 1.06M | 1.08M | 1.05M | 1.40M | 1.44M |
| Depreciation & Amortization | 48.50K | 66.00K | 72.30K | 73.40K | 74.80K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.53M | 1.57M | 1.58M | 2.01M | 2.23M |
| Operating Income | -1.48M | -1.53M | -1.56M | -1.99M | -2.21M |
| Income Before Tax | -1.48M | -1.73M | -2.42M | -2.83M | -2.93M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.48 | -1.73 | -2.42 | -2.83 | -2.93 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.48M | -1.73M | -2.42M | -2.83M | -2.93M |
| EBIT | -1.48M | -1.53M | -1.56M | -1.99M | -2.21M |
| EBITDA | -1.48M | -1.51M | -1.53M | -1.93M | -2.15M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.23B | 1.00B | 788.10M | 765.99M | 744.83M |
| Average Diluted Shares Outstanding | 1.32B | 1.04B | 798.13M | 785.48M | 764.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |